NO912758L - Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger. - Google Patents

Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger.

Info

Publication number
NO912758L
NO912758L NO91912758A NO912758A NO912758L NO 912758 L NO912758 L NO 912758L NO 91912758 A NO91912758 A NO 91912758A NO 912758 A NO912758 A NO 912758A NO 912758 L NO912758 L NO 912758L
Authority
NO
Norway
Prior art keywords
flupirtin
active substance
fight against
against muscle
muscle tensions
Prior art date
Application number
NO91912758A
Other languages
English (en)
Norwegian (no)
Other versions
NO912758D0 (no
Inventor
Michael Lobisch
Ralph Venhaus
Bernd Nickel
Istvan Szelenyi
Juergen Engel
Peter Emig
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO912758D0 publication Critical patent/NO912758D0/no
Publication of NO912758L publication Critical patent/NO912758L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Golf Clubs (AREA)
  • Details Of Television Scanning (AREA)
  • Paints Or Removers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
NO91912758A 1990-07-14 1991-07-12 Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger. NO912758L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022442 1990-07-14
IN421CA1991 IN172468B (enEXAMPLES) 1990-07-14 1991-06-04

Publications (2)

Publication Number Publication Date
NO912758D0 NO912758D0 (no) 1991-07-12
NO912758L true NO912758L (no) 1992-01-15

Family

ID=25895002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912758A NO912758L (no) 1990-07-14 1991-07-12 Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger.

Country Status (30)

Country Link
US (2) US5162346A (enEXAMPLES)
EP (2) EP0467164B1 (enEXAMPLES)
KR (1) KR0182811B1 (enEXAMPLES)
CN (1) CN1070700C (enEXAMPLES)
AT (2) ATE206919T1 (enEXAMPLES)
AU (1) AU634073B2 (enEXAMPLES)
CA (1) CA2046943C (enEXAMPLES)
CZ (1) CZ280879B6 (enEXAMPLES)
DE (3) DE59109222D1 (enEXAMPLES)
DK (2) DK0467164T3 (enEXAMPLES)
EG (1) EG19814A (enEXAMPLES)
ES (2) ES2164111T3 (enEXAMPLES)
GR (1) GR3019179T3 (enEXAMPLES)
HR (1) HRP920667B1 (enEXAMPLES)
HU (1) HU206973B (enEXAMPLES)
IE (1) IE74688B1 (enEXAMPLES)
IL (1) IL98810A (enEXAMPLES)
IN (1) IN172468B (enEXAMPLES)
LT (1) LT3593B (enEXAMPLES)
LV (1) LV10048B (enEXAMPLES)
MC (1) MC2272A1 (enEXAMPLES)
MX (1) MX9100160A (enEXAMPLES)
NO (1) NO912758L (enEXAMPLES)
NZ (1) NZ238940A (enEXAMPLES)
PT (1) PT98291B (enEXAMPLES)
RO (1) RO108220B1 (enEXAMPLES)
RU (1) RU2070408C1 (enEXAMPLES)
SI (1) SI9111227B (enEXAMPLES)
SK (1) SK279567B6 (enEXAMPLES)
ZA (1) ZA915466B (enEXAMPLES)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0560092T3 (da) * 1992-03-11 1998-08-10 Asta Medica Ag Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
DE19541405A1 (de) * 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
WO2001008682A2 (de) * 1999-08-03 2001-02-08 Awd.Pharma Gmbh & Co. Kg Verwendung von flupirtin zur linderung von schmerzen bei degenerativen gelenkerkrankungen von hunden und katzen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
RU2213565C1 (ru) * 2002-06-24 2003-10-10 Общество с ограниченной ответственностью "Паркинфарм" Способ лечебного воздействия на организм пациента при лечении болезни паркинсона
DE10255415A1 (de) * 2002-11-28 2004-06-09 Bayer Healthcare Ag Dermale Applikation von Flupirtin
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US7799832B2 (en) 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20050196461A1 (en) * 2004-01-14 2005-09-08 Udell Ronald G. Ceramide formulations suitable for oral administration
CA2554959A1 (en) * 2004-01-29 2005-08-11 Neuromolecular, Inc. Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US8058291B2 (en) 2005-04-06 2011-11-15 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of CNS-related conditions
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20090318507A2 (en) * 2006-05-02 2009-12-24 Chris Rundfeldt Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like Symptoms
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
AU2007288253B2 (en) * 2006-08-23 2013-05-02 Xenon Pharmaceuticals Inc. Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
AU2007325629A1 (en) * 2006-11-28 2008-06-05 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
CN101790374A (zh) * 2007-08-01 2010-07-28 H.隆德贝克有限公司 Kcnq钾通道开放剂用于减轻多巴胺能系统受到干扰的障碍或病症的症状或治疗这种障碍或病症的用途
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
ES2347119B2 (es) * 2009-04-22 2011-04-28 Universidad De Santiago De Compostela Nanocapsulas de poliarginina.
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
JP6251667B2 (ja) * 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen
HUE070295T2 (hu) 2019-10-10 2025-05-28 Xenon Pharmaceuticals Inc Szelektív kálium csatorna modulátor szilárd állapotú kristályos formái
EP4054580A1 (en) 2019-11-08 2022-09-14 Xenon Pharmaceuticals Inc. Methods of treating depressive disorders
KR20240004241A (ko) 2021-02-09 2024-01-11 제논 파마슈티칼스 인크. 무쾌감증의 치료에 사용하기 위한 전압-게이트 칼륨 채널 오프너

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
DE3133519A1 (de) 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
ATE46265T1 (de) * 1985-01-23 1989-09-15 Asta Pharma Ag Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika.
DE3604575A1 (de) * 1985-02-23 1986-08-28 Degussa Ag, 6000 Frankfurt Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
DE3663775D1 (en) * 1985-02-23 1989-07-13 Asta Pharma Ag Combination of flupirtin with spasmolytics having an anticholinergic effect
FI855016L (fi) * 1985-06-28 1986-12-29 Degussa Synergistisk kombination av flupirtin och 4-acetamido-fenol.

Also Published As

Publication number Publication date
HRP920667A2 (en) 1996-10-31
EP0659410A2 (de) 1995-06-28
IL98810A0 (en) 1992-07-15
MX9100160A (es) 1992-02-28
LT3593B (en) 1995-12-27
RO108220B1 (ro) 1994-03-31
EP0467164B1 (de) 1996-01-31
SI9111227B (sl) 2000-12-31
CA2046943C (en) 1996-03-12
ES2082887T3 (es) 1996-04-01
IE74688B1 (en) 1997-07-30
ES2164111T3 (es) 2002-02-16
CS210191A3 (en) 1992-02-19
CZ280879B6 (cs) 1996-04-17
EG19814A (en) 1996-02-29
DK0467164T3 (da) 1996-03-04
HUT59313A (en) 1992-05-28
KR0182811B1 (ko) 1999-05-01
DE4122166A1 (de) 1992-01-16
LTIP919A (en) 1995-03-27
EP0659410B1 (de) 2001-10-17
CA2046943A1 (en) 1992-01-15
PT98291A (pt) 1992-05-29
IL98810A (en) 1996-01-19
EP0467164A3 (en) 1992-04-15
ZA915466B (en) 1992-04-29
LV10048A (lv) 1994-05-10
CN1058716A (zh) 1992-02-19
GR3019179T3 (en) 1996-06-30
NZ238940A (en) 1997-05-26
US5284861A (en) 1994-02-08
EP0467164A2 (de) 1992-01-22
DK0659410T3 (da) 2001-12-27
SI9111227A (en) 1995-06-30
CN1070700C (zh) 2001-09-12
NO912758D0 (no) 1991-07-12
EP0659410A3 (de) 1995-10-25
AU634073B2 (en) 1993-02-11
MC2272A1 (fr) 1993-06-23
ATE206919T1 (de) 2001-11-15
HRP920667B1 (en) 1998-06-30
HU912359D0 (en) 1991-12-30
ATE133564T1 (de) 1996-02-15
DE59107331D1 (de) 1996-03-14
LV10048B (en) 1995-06-20
KR920002147A (ko) 1992-02-28
AU8040391A (en) 1992-01-16
IE912451A1 (en) 1992-01-15
PT98291B (pt) 1999-01-29
IN172468B (enEXAMPLES) 1993-08-14
RU2070408C1 (ru) 1996-12-20
DE59109222D1 (de) 2001-11-22
HU206973B (en) 1993-03-01
SK279567B6 (sk) 1999-01-11
US5162346A (en) 1992-11-10

Similar Documents

Publication Publication Date Title
NO912758D0 (no) Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger.
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ATE69376T1 (de) Haarwuchsmittel.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
BR1100384A (pt) Composto e formulação farmacêutica
NO944339L (no) Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
NO307364B1 (no) Anvendelse av melatoninderivater
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
SE8703308D0 (sv) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
ATE74505T1 (de) Schmerzpraeparat.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
IT224697Z2 (it) Apparecchiatura per l'esecuzione di trattamenti fitosanitari.